Jumpcode Genomics, founded in 2016 and led by CEO Yaron Hakak, Ph.D., develops patented CRISPRclean technology to improve next-generation sequencing workflows. The CRISPRclean process is designed to integrate with standard NGS workflows and is compatible with most commercially available library preparation solutions. Its products are used by researchers across basic research, infectious disease, oncology and consumer genomics. The company announced a Series B financing in January 2021, reflecting a notable capital raise in its recent history. In conjunction with that round, Frank Witney joined Jumpcode’s board of directors.

Total raised

$21M

Funding rounds

1

Latest round

Series B

Latest activity

Feb 2021